Indo Us Bio-Tech Ltd Board Meeting Approves Appointment of Independent Director and Statutory Auditor
Indo Us Bio-Tech Ltd, at its Board meeting held on July 03, 2026, made key decisions regarding its board structure and statutory oversight. The Board approved the appointment of Mrs. Hemanshi Darsh Soni as an Additional Director (Non-Executive Independent) and ratified the appointment of M/s. Bhagat & Associates as the company's Statutory Auditor, both subject to subsequent shareholder approval through a Postal Ballot process.The appointment of Mrs. Hemanshi Darsh Soni comes after the Board had previously approved her role as an Additional Director for a five-year period, effective from April 21, 2026. As an Additional Director in the capacity of Non-Executive Independent Director (NEID), Mrs. Soni is reported to be affiliated with the service sector and possesses expertise in building high-performance teams, implementing strong sales, marketing and service networks, and putting robust operational processes in place. The company confirmed that she holds no relationship with any director on the Board and does not hold directorship in any other listed entity.
In parallel, the Board approved the appointment of M/s. Bhagat & Associates, Chartered Accountants (FRN: 101100W), as Statutory Auditor. This approval was granted on June 16, 2026, and the auditors will be responsible for the company starting from that date. M/s. Bhagat & Associates is a firm registered with the Institute of Chartered Accountants of India and provides services in audit, taxation, assurance, and advisory fields.
Key details regarding the appointments are as follows:
| Appointment Detail | Mrs. Hemanshi Darsh Soni (NEID) | M/s. Bhagat & Associates (Statutory Auditor) |
|---|---|---|
| Role | Additional Director / Non-Executive Independent Director | Statutory Auditor |
| Term of Appointment | 5 years, effective from April 21, 2026 | Subject to shareholder approval for a period of 5 years (effective from June 16, 2026) |
| Board Approval Date | July 03, 2026 | June 16, 2026 |
Process and Timeline of Events
The Board of Directors appointed M/S Amrish Gandhi & Associates, a Practicing Company Secretary, to serve as the scrutinizer for the postal ballot process. The company also specified Friday, June 26, 2026, as the Specified Date/CutOff for determining shareholder eligibility for e-voting purposes.The calendar of events for the proposed Postal Ballot and electronic voting process includes several critical dates:
| Sr. No. | Particulars | Dates |
|---|---|---|
| 1 | Date of Board Resolution authorizing the Director(s) and Company Secretary for the Postal Ballot process | July 3, 2026 |
| 2 | Specified date/Cut off for E-voting eligibility determination | June 26, 2026 |
| 3 | Date of completion of Notice dispatch by electronic means | July 4, 2026 |
| 4 | Date of publishing Advertisement in Newspaper | July 6, 2026 |
| 5 | Date of Commencement of voting by Electronic Mode | July 5, 2026 |
| 6 | End date of voting by Electronic Mode | August 3, 2026 |
| 7 | Date on which Resolution will be deemed to be passed | August 3, 2026 |
| 8 | Date of submission of the Report by the Scrutinizer | On or before August 5, 2026 |
| 9 | Date of declaration of the result | On or before August 5, 2026 |
INDOUS Stock Price Movement
Indo Us Biotech Limited shares edged higher today, settling at ₹89.15 after gaining 1.13%. The stock saw a total traded volume of 2,790 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: